Robert L. Eil, M.D.
- Assistant Professor of Surgery, Division of Surgical Oncology, School of Medicine
Biography
As a surgeon, Dr. Eil cares for patients who have cancers of the liver, bile ducts and pancreas. As a scientist, Dr. Eil studies immunotherapy for these types of cancer. Immunotherapy supports the body’s natural immune response to cancer. Dr. Eil worked for three years at the National Cancer Institute. While there, he made discoveries about how immune cells fight cancer. This research is helping scientists understand and treat cancer. He brings his surgical and scientific knowledge together at OHSU for patients with liver and pancreatic cancer.
Dr. Eil and his wife have two young children. They enjoy traveling and spending time outside as a family.
Education and training
-
Degrees
- B.S., 2005, Tulane University
- M.D., 2010, University of North Carolina School of Medicine
-
Residency
- General Surgery, OHSU, 2010-2018
-
Fellowship
- Tumor Immunology & Immunotherapy, Surgery Branch, National Cancer Institute, NIH, 2013-2016
- Complex General Surgical Oncology, Memorial Sloan Kettering Cancer Center, 2018-2020
-
Certifications
- American Board of Surgery, 2019
- Complex General Surgical Oncology, 2021
Areas of interest
- Cholangiocarcinoma
- Colorectal Liver Metastasis
- Tumor induced immune suppression
- T cell ion transport
- T cell engineering
- Translational science
- Investigator initiated clinical trials
Additional information
Honors and awards
- Resident Paper of the Year, OHSU, 2017
- Thoracic Surgery Resident of the Year, OHSU, 2017
Publications
Elsevier pure profilePublications
A Modified Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases Treated with Hepatic Arterial Infusion
Annals of surgical oncologyHepatic signal transducer and activator of transcription-3 signalling drives early-stage pancreatic cancer cachexia via suppressed ketogenesis
Journal of Cachexia, Sarcopenia and MuscleIntracellular K+ Limits T-cell Exhaustion and Preserves Antitumor Function
Cancer Immunology ResearchHepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases
Surgery (United States)Surgical timing after preoperative chemotherapy is associated with oncologic outcomes in resectable colorectal liver metastases
Journal of surgical oncologyCCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function
ImmunologyConventional hepatic arterial anatomy? Novel findings and insights of a multi-disciplinary hepatic arterial infusion pump program
American journal of surgerySurgical and oncologic outcomes following repeat hepatic resection of colorectal liver metastasis
American journal of surgeryBACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression
Journal of Experimental MedicineMulti-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive Immunotherapies
Cancer CellT cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Journal of Clinical InvestigationT cell stemness and dysfunction in tumors are triggered by a common mechanism
ScienceIdentification of essential genes for cancer immunotherapy
NatureInhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
JCI InsightNovel "Elements" of immune suppression within the tumor microenvironment
Cancer Immunology ResearchBACH2 regulates CD8 + T cell differentiation by controlling access of AP-1 factors to enhancers
Nature ImmunologyFas/CD95 prevents autoimmunity independently of lipid raft localization and efficient apoptosis induction
Nature communicationsIonic immune suppression within the tumour microenvironment limits T cell effector function
NatureMemory T cell-driven differentiation of naive cells impairs adoptive immunotherapy
Journal of Clinical InvestigationMitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy
Cell MetabolismOxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
CellSignificance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors
American journal of surgeryAkt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics
Cancer ResearchCish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance
Journal of Experimental MedicineNomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer
CancerTraumatic ventricular septal defect resulting in severe pulmonary hypertension
Journal of Surgical Case Reports